Wang Jieying, Dong Jinhui, Chen Zhuolin, Xu Yuni, Qiu Wenhua, Chen Shaowen, Pei Hua, Zhong Yeteng
Department of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570311, People's Republic of China.
BMC Infect Dis. 2025 Aug 1;25(1):973. doi: 10.1186/s12879-025-11312-8.
Multidrug-resistant tuberculosis (MDR-TB) remains a major public health challenge in China. Hainan, China's largest tropical island, possesses distinct socio-geographical features. However, the drug resistance patterns and molecular epidemiology of MDR-TB in this region have not been fully elucidated. This study aimed to assess the correlation between drug resistance genotypes and phenotypic resistance levels in multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) strains collected from Hainan Island, using whole-genome sequencing (WGS) and phenotypic drug susceptibility testing (DST).
MDR-MTB strains isolated from patients on Hainan Island (2019-2021) were analyzed. Minimum inhibitory concentrations (MIC) for 15 anti-TB drugs were determined by broth microdilution (BMD). Whole-genome sequencing (WGS) was performed using Illumina NovaSeq 6000. Genotypic resistance was predicted via TB-Profiler, and correlations between resistance mutations and MIC levels were assessed.
A total of 209 MDR-MTB strains were analyzed. Strains of lineage 2.2 exhibited significantly higher resistance to ethambutol (EMB) compared to non-lineage 2 strains (P < 0.05). The sensitivity of WGS in predicting resistance to first-line drugs isoniazid (INH), rifampicin (RIF), EMB, and pyrazinamide (PZA) was 94.7%, 99.0%, 96.5%, and 80.8%, respectively. However, specificity for EMB and PZA was lower at 60.2% and 79.4%. WGS also demonstrated high sensitivity and specificity (> 95%) for second-line injectable aminoglycosides (amikacin [AMK], capreomycin [CPM], and kanamycin [KM]), but sensitivity for other second-line drugs except for fluoroquinolone drug moxifloxacin (MOX, 94.4%) was below 80.0%. Notably, mutations in katG_S315T, rpoB_S450L, and gyrA_D94G were strongly associated with high-level resistance, while mutations in fabG1, ahpC, embA promoters, and gyrA at codon 90 were linked to low-level resistance.
This study quantitatively demonstrates the relationship between specific drug resistance genotypes and resistance levels. It is the first to characterize the regional resistance spectrum of MDR-MTB strains on Hainan Island. These findings offer a novel foundation for MIC-based dose adjustment and the optimization of treatment strategies in this region. TRIAL REGISTRATION: MR-46-23-020530. Date of registration:2023-07-03.
耐多药结核病(MDR-TB)仍是中国面临的一项重大公共卫生挑战。中国最大的热带岛屿海南具有独特的社会地理特征。然而,该地区耐多药结核病的耐药模式和分子流行病学尚未完全阐明。本研究旨在通过全基因组测序(WGS)和表型药物敏感性试验(DST),评估从海南岛收集的耐多药结核分枝杆菌(MDR-MTB)菌株的耐药基因型与表型耐药水平之间的相关性。
对2019 - 2021年从海南岛患者中分离出的MDR-MTB菌株进行分析。采用肉汤微量稀释法(BMD)测定15种抗结核药物的最低抑菌浓度(MIC)。使用Illumina NovaSeq 6000进行全基因组测序(WGS)。通过TB-Profiler预测基因型耐药性,并评估耐药突变与MIC水平之间的相关性。
共分析了209株MDR-MTB菌株。与非2型菌株相比,2.2型菌株对乙胺丁醇(EMB)的耐药性显著更高(P < 0.05)。WGS预测一线药物异烟肼(INH)、利福平(RIF)、EMB和吡嗪酰胺(PZA)耐药性的敏感性分别为94.7%、99.0%、96.5%和80.8%。然而,对EMB和PZA的特异性较低,分别为60.2%和79.4%。WGS对二线注射用氨基糖苷类药物(阿米卡星[AMK]、卷曲霉素[CPM]和卡那霉素[KM])也表现出高敏感性和特异性(> 95%),但除氟喹诺酮类药物莫西沙星(MOX,94.4%)外,对其他二线药物的敏感性低于80.0%。值得注意的是,katG_S315T、rpoB_S450L和gyrA_D94G突变与高水平耐药密切相关,而fabG1、ahpC、embA启动子和第90位密码子的gyrA突变与低水平耐药有关。
本研究定量证明了特定耐药基因型与耐药水平之间的关系。这是首次对海南岛MDR-MTB菌株的区域耐药谱进行特征描述。这些发现为该地区基于MIC的剂量调整和治疗策略优化提供了新的依据。试验注册:MR - 46 - 23 - 020530。注册日期:2023 - 07 - 03。